|
Chapman MA, Sive J, Ambrose J, Roddie C, Counsell N, Lach A, et al |
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature |
|
Blood |
|
Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Ro... |
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia |
|
Nature |
|
Pritchard-Jones K, Moroz V, Vujanic G, Powis M, Walker J, Messahel B, Hobso... |
Children's Cancer and Leukaemia Group (CCLG) Renal Tumours Group. Trea... |
|
Annals of Oncology |
|
Cooke SL, Temple J, Macarthur S, Zahra MA, Tan LT, Crawford RA, Ng CK, Jime... |
Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer |
|
Br J Cancer. |
|
Doupe, DP, Alcolea, MP, Roshan, A, Zhang, G, Klein, AM, Simons, BD, and Jon... |
A single progenitor population switches behavior to maintain and repair esophageal epithelium |
|
Science |
|
Thurtle DR, Greenberg DC, Lee LS, Huang HH, Pharoah PD, Gnanapragasam VJ |
Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model. |
|
PLOS Medicine |
|
Schwartzentruber, J., et al. |
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma |
|
Nature |
|
Alam, I. S., Neves, A. A., Witney, T. H., Boren, J., and Brindle, K. M. |
Comparison of the C2A Domain of Synaptotagmin-I and Annexin-V as probes for detecting cell death |
|
Bioconjugate Chem. |
|
M. Erdelyi;E. Rees;D. Metcalf;G. S. Schierle;L. Dudas;J. Sinko;A. E. Knight... |
Correcting chromatic offset in multicolor super-resolution localization mic... |
|
Opt Express |
|
J.A. Harrington, G.M. Wheeler, M.J. Sweeting, A.P. Mander, D.I. Jodrell. |
Adaptive designs for dual-agent phase I dose-escalation studies |
|
Nat Rev Clin Oncol |
